TLN-4601 is prob the cure for cancer
The molecule binds to the PBR receptors enters the cancerous cell and kills it via the Ras path.
The binding mecanism is now understood and the killing effect is define.
Targetted test population can now be better define and odds of PII success is quite high.
6/7 patient at max dosage were in stable after six cycle of treatment.
We are talking about terminal ill people with refractive cancers.
If this company was worthless no one would come forth before premiliminary results due in Q1 2009 and force a low ball bid.
This stock is under the radar and insanely cheap.
market cap is 6,4 millions at 0,20$
I could buy the company if I wanted ... but would not have cash to sustain the burn rate... LOL.
Anyway.
For a retail investor, bid is more than 0,43 (cash value). Bidder will offer something for the 3 compounds.
Possibly 2$ would a u can't refuse deal.
Management only card to play is to get external opinion to show how undervalued the bid is and get better price or bid.
Market reaction will be slow but volume is already building.